RARE

Ultragenyx (RARE)

US
$ 00%

Price Chart

Key Statistics

Market Cap
$ 2.84B
P/E Ratio
0.00
Revenue (TTM)
$ 610.16M
Volume
0
52W High
$ 59.90
52W Low
$ 25.81
Dividend Yield
0.00%
Beta
0.21

Technicals

50-Day MA
29.4827
200-Day MA
37.31
52 Week High
59.9
52 Week Low
25.81

About RARE

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare g.

Employees
1294
Headquarters
Novato, CA
CEO
Dr. Emil D. Kakkis M.D., Ph.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg